News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,884 Results
Type
Article (87366)
Company Profile (759)
Press Release (771733)
Multimedia
Podcasts (169)
Webinars (28)
Section
Business (233029)
Career Advice (4137)
Deals (39788)
Drug Delivery (134)
Drug Development (91235)
Employer Resources (202)
FDA (18272)
Job Trends (17394)
News (397327)
Policy (39920)
Tag
Academia (3003)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (142)
Alzheimer's disease (1672)
Antibody-drug conjugate (ADC) (220)
Approvals (18279)
Artificial intelligence (476)
Autoimmune disease (67)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (122)
Brain cancer (52)
Breast cancer (471)
Cancer (3756)
Cardiovascular disease (333)
Career advice (3553)
Career pathing (37)
CAR-T (240)
CDC (54)
Cell therapy (668)
Cervical cancer (32)
Clinical research (75227)
Collaboration (1350)
Company closure (4)
Compensation (919)
Complete response letters (59)
COVID-19 (2948)
CRISPR (81)
C-suite (562)
Cystic fibrosis (132)
Data (4166)
Decentralized trials (2)
Denatured (60)
Depression (108)
Diabetes (444)
Diagnostics (7080)
Digital health (35)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (228)
Drug pricing (182)
Drug shortages (36)
Duchenne muscular dystrophy (197)
Earnings (98717)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132715)
Executive appointments (976)
FDA (20651)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1220)
Gene editing (170)
Generative AI (45)
Gene therapy (531)
GLP-1 (1011)
Government (5374)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (51)
Infectious disease (3179)
Inflammatory bowel disease (184)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (182)
Interviews (815)
IPO (17925)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (634)
Leadership (32)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (534)
Lymphoma (258)
Machine learning (27)
Management (66)
Manufacturing (619)
MASH (133)
Medical device (14853)
Medtech (14874)
Mergers & acquisitions (22721)
Metabolic disorders (1134)
Multiple sclerosis (136)
NASH (23)
Neurodegenerative disease (221)
Neuropsychiatric disorders (59)
Neuroscience (2679)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (56)
Obesity (554)
Opinion (309)
Ovarian cancer (123)
Pain (161)
Pancreatic cancer (164)
Parkinson's disease (236)
Partnered (28)
Patents (406)
Patient recruitment (296)
Peanut (57)
People (66194)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23193)
Phase II (32674)
Phase III (24572)
Pipeline (2626)
Policy (291)
Postmarket research (3554)
Preclinical (10469)
Press Release (72)
Prostate cancer (191)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (645)
Real estate (7421)
Recruiting (78)
Regulatory (27906)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (13)
RNA editing (15)
RSV (70)
Schizophrenia (133)
Series A (202)
Series B (149)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (91)
The Weekly (107)
Vaccines (1031)
Venture capital (66)
Weight loss (391)
Women's health (58)
Worklife (21)
Date
Today (165)
Last 7 days (594)
Last 30 days (2444)
Last 365 days (33638)
2025 (25423)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (80)
Alaska (7)
Arizona (301)
Arkansas (14)
Asia (50891)
Australia (8943)
California (9247)
Canada (2806)
China (869)
Colorado (393)
Connecticut (411)
Delaware (254)
Europe (116955)
Florida (1359)
Georgia (310)
Hawaii (3)
Idaho (67)
Illinois (801)
India (47)
Indiana (450)
Iowa (19)
Japan (305)
Kansas (123)
Kentucky (37)
Louisiana (20)
Maine (77)
Maryland (1253)
Massachusetts (6958)
Michigan (307)
Minnesota (556)
Mississippi (4)
Missouri (116)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2555)
New Mexico (32)
New York (2525)
North Carolina (1393)
North Dakota (10)
Northern California (4150)
Ohio (287)
Oklahoma (20)
Oregon (50)
Pennsylvania (1927)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3535)
Tennessee (148)
Texas (1445)
United States (34234)
Utah (274)
Virginia (243)
Washington D.C. (82)
Washington State (796)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,884 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tesamorelin: Exploring the Research Potential of a Growth Hormone-Releasing Peptide
October 8, 2025
·
1 min read
Radiopharmaceuticals
Sanofi Comes for Novartis’ Radiopharma Crown With ‘Clinically Meaningful’ Pancreatic Tumor Data
Sanofi’s Orano Med-partnered radioligand therapy AlphaMedix achieved all primary efficacy endpoints, which included a measure of overall response rate, in the mid-stage ALPHAMEDIX-02 study.
October 8, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Neural Portfolio Company Hanf.com Reports Strong Fiscal 2024 Results with 65% Revenue Growth, Positive Cash Flow and Double-Digit Operating Margin; Continued Growth in 2025; First Half Revenues Up 31% Year-Over-Year
October 8, 2025
·
8 min read
Press Releases
PharmaTher Provides Update on Ketamine Program for LID-Parkinson’s Disease
October 8, 2025
·
9 min read
Press Releases
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrants
October 8, 2025
·
5 min read
Press Releases
Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms
October 8, 2025
·
2 min read
Press Releases
Wemedoo AG named Innovator Start-up of the Year 2025 by SCDM
October 8, 2025
·
1 min read
Press Releases
Radiation Oncology Market Size to Surpass USD 32.82 Billion by 2034
October 8, 2025
·
1 min read
Press Releases
PumasAI Unveils PumasAide, a Built-In AI Assistant to Accelerate Pharmacometric Research
October 8, 2025
·
1 min read
Press Releases
SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy
October 8, 2025
·
1 min read
1 of 85,989
Next
